A clinical trial of Ayurvedic intervention to cure Covid-19 patients with mild and moderate symptoms held at the Victoria Hospital, Bengaluru, has showed “positive results”.

The trial, approved by the Ethics Committee of Bengaluru Medical College with the nod from the Clinical Trials Registry of India, was carried out on 10 Covid-positive patients from June seven to 25.

“All the patients were cured and tested negative for the virus after nine days of treatment. Two ayurvedic tablets were administered to them thrice a day during the period… I’ve sought permission from the government to treat larger number of people. The more samples tested, the more will be its approval ratings,” Dr Giridhara Kaje, MD and Chief Physician, Prashanthi Ayurvedic Centre, Rajajinagar, who initiated the trial told the AIR.

Dr Smitha S Segu, Nodal Officer of the Covid Core Committee, Bangalore Medical College and Research Institute said the Ayurvedic treatment was provided in addition to regular treatment and that all the patients recovered well.

The development comes even as the AYUSH Ministry has stated that the results of its clinical trials and evaluations involving ayurvedic formulations will be out only by September end due to the strict standards involved and the fool-proof approach adopted.

“We’ve already initiated trial of AYUSH 64, a poly-herbal antimalarial formulation. The clinical research of ‘Ashwagandha’ will start this week while that regarding Ayurveda medicines like Giloy will commence soon. The last one is happening at multiple places like Jamnagar and Jodhpur... By September end, we’ll have some clarity about the results. Then we will share with the public,” said Dr J L N Sastry, Chief Executive Officer, National Medicinal Plant Board.

He was speaking as a panelist in the first of the international webinar series being organized by the Ayush Valley Foundation in association with the Ayurveda & Health Tourism Magazine on the topic ‘Can we live with Corona’ last week.